pharmaceutical investing Aquinox Announces Topline Results of Phase 3 LEADERSHIP 301 Clinical Trial in Interstitial Cystitis/Bladder Pain Syndrome
Finlay Minerals Announces Increase in Size of Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units
